Ali Mazanderani - 03 Aug 2026 Form 4 Insider Report for LESAKA TECHNOLOGIES INC (LSAK)

Reporting relationship: Executive Chairman, Director
Issuer ticker: LSAK
Reported as of: 03 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Oct 2026, 08:30:24 UTC
Prior SEC filing: 05 Mar 2026
Next SEC filing: 17 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Ali Mazanderani

Key filing fact

Ali Mazanderani filed Form 4 for LESAKA TECHNOLOGIES INC (LSAK) on 14 Oct 2026.

Key facts

This page summarizes Ali Mazanderani's Form 4 filing for LESAKA TECHNOLOGIES INC (LSAK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Oct 2026, 08:30.

Change

Previous filing in this sequence was filed on 05 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001812168 Primary reporting owner

Mazanderani Ali

Relationship: Executive Chairman, Director
Address: 7 PARKS BOULEVARD, OXFORD PARKS, DUNKELD, JOHANNESBURG, SOUTH AFRICA
Signature: /s/ Ali Mazanderani
Signature date: 14 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LSAK transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
Shares: +1,000,000
Change %
Price: $0.000000^*
Shares after: 1,000,000
Date: 03 Aug 2026
Ownership: Direct
Underlying class: Common stock
Underlying amount: 1,000,000
Exercise price: $5.00
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The stock options were approved by the board of directors on May 12, 2026, subject to shareholder approval of the grant. Shareholders approved the grant on August 3, 2026.

Footnote F2

The Stock Options will vest on April 1, 2028, provided that the recipient provides continuous employment through April 1, 2028. The stock options may only be exercised during a period commencing from April 1, 2029, to April 1, 2030.